Vaccitech shares are trading higher after Alliance Global Partners initiated a Buy rating on the stock and announced a $12 price target.
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners has initiated a Buy rating on Vaccitech and announced a $12 price target, leading to a rise in Vaccitech's stock.
September 25, 2023 | 2:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vaccitech's stock is trading higher after Alliance Global Partners initiated a Buy rating and set a $12 price target.
The initiation of a Buy rating and a price target of $12 by Alliance Global Partners is a positive signal for Vaccitech. This suggests that the analyst firm sees potential upside in the stock, which can lead to increased investor interest and a potential increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100